These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

204 related items for PubMed ID: 9916938

  • 1. Inhibition of NF-kappaB activation and augmentation of IkappaBbeta by secretory leukocyte protease inhibitor during lung inflammation.
    Lentsch AB, Jordan JA, Czermak BJ, Diehl KM, Younkin EM, Sarma V, Ward PA.
    Am J Pathol; 1999 Jan; 154(1):239-47. PubMed ID: 9916938
    [Abstract] [Full Text] [Related]

  • 2. Anti-inflammatory effects of mutant forms of secretory leukocyte protease inhibitor.
    Mulligan MS, Lentsch AB, Huber-Lang M, Guo RF, Sarma V, Wright CD, Ulich TR, Ward PA.
    Am J Pathol; 2000 Mar; 156(3):1033-9. PubMed ID: 10702419
    [Abstract] [Full Text] [Related]

  • 3. Secretory leucoprotease inhibitor prevents lipopolysaccharide-induced IkappaBalpha degradation without affecting phosphorylation or ubiquitination.
    Taggart CC, Greene CM, McElvaney NG, O'Neill S.
    J Biol Chem; 2002 Sep 13; 277(37):33648-53. PubMed ID: 12084717
    [Abstract] [Full Text] [Related]

  • 4. Regulatory effects of endogenous protease inhibitors in acute lung inflammatory injury.
    Gipson TS, Bless NM, Shanley TP, Crouch LD, Bleavins MR, Younkin EM, Sarma V, Gibbs DF, Tefera W, McConnell PC, Mueller WT, Johnson KJ, Ward PA.
    J Immunol; 1999 Mar 15; 162(6):3653-62. PubMed ID: 10092827
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Secretory leucoprotease inhibitor binds to NF-kappaB binding sites in monocytes and inhibits p65 binding.
    Taggart CC, Cryan SA, Weldon S, Gibbons A, Greene CM, Kelly E, Low TB, O'neill SJ, McElvaney NG.
    J Exp Med; 2005 Dec 19; 202(12):1659-68. PubMed ID: 16352738
    [Abstract] [Full Text] [Related]

  • 8. Secretory leukocyte protease inhibitor inhibits expression of polymeric immunoglobulin receptor via the NF-κB signaling pathway.
    Mikami Y, Iwase T, Komiyama Y, Matsumoto N, Oki H, Komiyama K.
    Mol Immunol; 2015 Oct 19; 67(2 Pt B):568-74. PubMed ID: 26239418
    [Abstract] [Full Text] [Related]

  • 9. Adenoviral gene delivery of elafin and secretory leukocyte protease inhibitor attenuates NF-kappa B-dependent inflammatory responses of human endothelial cells and macrophages to atherogenic stimuli.
    Henriksen PA, Hitt M, Xing Z, Wang J, Haslett C, Riemersma RA, Webb DJ, Kotelevtsev YV, Sallenave JM.
    J Immunol; 2004 Apr 01; 172(7):4535-44. PubMed ID: 15034071
    [Abstract] [Full Text] [Related]

  • 10. Effects of secretory leukocyte protease inhibitor on the tumor necrosis factor-alpha production and NF-kappaB activation of lipopolysaccharide-stimulated macrophages.
    Sano C, Shimizu T, Tomioka H.
    Cytokine; 2003 Jan 07; 21(1):38-42. PubMed ID: 12668158
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Essential role of alveolar macrophages in intrapulmonary activation of NF-kappaB.
    Lentsch AB, Czermak BJ, Bless NM, Van Rooijen N, Ward PA.
    Am J Respir Cell Mol Biol; 1999 Apr 07; 20(4):692-8. PubMed ID: 10101001
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. NF-kappaB activation during IgG immune complex-induced lung injury: requirements for TNF-alpha and IL-1beta but not complement.
    Lentsch AB, Czermak BJ, Bless NM, Ward PA.
    Am J Pathol; 1998 May 07; 152(5):1327-36. PubMed ID: 9588901
    [Abstract] [Full Text] [Related]

  • 17. Endogenous secretory leukocyte protease inhibitor inhibits microbial-induced monocyte activation.
    Nugteren S, Simons-Oosterhuis Y, Menckeberg CL, Hulleman-van Haaften DH, Lindenbergh-Kortleve DJ, Samsom JN.
    Eur J Immunol; 2023 Feb 07; 53(2):e2249964. PubMed ID: 36480463
    [Abstract] [Full Text] [Related]

  • 18. Suppression of lung inflammation in rats by prevention of NF-kappaB activation in the liver.
    Lancaster LH, Christman JW, Blackwell TR, Koay MA, Blackwell TS.
    Inflammation; 2001 Feb 07; 25(1):25-31. PubMed ID: 11293663
    [Abstract] [Full Text] [Related]

  • 19. Temporal induction of secretory leukocyte protease inhibitor (SLPI) in odontoblasts by lipopolysaccharide and wound infection.
    Choi BD, Jeong SJ, Wang G, Kim HJ, Kim BO, Hwang HK, Lim DS, Kim SH, Jeong MJ.
    J Endod; 2009 Jul 07; 35(7):997-1002. PubMed ID: 19567322
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.